Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
Smartphone Video Enhances Parkinson’s DBS Programming
Researchers have introduced StimVision, a smartphone‑based system that records video of Parkinson’s patients performing motor tasks and converts the footage into quantitative kinematic data for deep brain stimulation (DBS) programming. The platform’s computer‑vision and machine‑learning algorithms generate metrics that align with clinical scales such as the UPDRS, enabling more precise and objective adjustment of stimulation parameters. Early trials show reduced programming time and improved accuracy, while the app’s ease of use promises broader adoption in diverse clinical settings. StimVision could transform DBS titration from an art into a data‑driven science.
Lab-Grown Mini Brain Models Offer New Hope for Diagnosing and Treating Alzheimer’s Disease
Johns Hopkins researchers created patient‑derived hindbrain organoids that faithfully reproduce Alzheimer’s molecular hallmarks. Using these mini‑brains, they tested the SSRI escitalopram, uncovering strikingly different serotonin‑signaling responses across individual organoids. Proteomic analysis of extracellular vesicles revealed disease‑related proteins that shifted with...
Lifting Weights Builds a Sharper Mind and Reduces Anxiety in Older Women
A three‑month randomized trial found that older women who engaged in resistance training—whether using heavier weights for eight to twelve reps or lighter weights for ten to fifteen reps—experienced significant gains in cognitive performance and marked reductions in depression and...
NCQA and West Health Collaborate to Enhance Integration of Behavioral Health Within Primary Care Systems
The National Committee for Quality Assurance (NCQA) and West Health have formed a strategic partnership to develop standardized quality measures that embed behavioral health into primary‑care settings. By combining NCQA’s measurement expertise with West Health’s Accelerator model, the alliance will...
STAT+: At AACR, a Provocative Use of CAR-T, Merck’s New Thing and Cancer’s Geography Problem
At the AACR 2026 meeting, early‑phase data showed Merck‑partnered CAR‑T therapy Carvykti eliciting deep responses in 20 high‑risk smoldering multiple myeloma patients, suggesting a preventive angle for a precursor disease. The conference also featured Merck’s first glimpse of an oncology...
Out-of-Network Pricing Lawsuits Test MultiPlan, Zelis Business Models
Healthcare providers have filed antitrust lawsuits alleging that insurers and pricing intermediaries Zelis and MultiPlan conspired to suppress out‑of‑network payments using proprietary repricing algorithms. The Zelis case survived a motion to dismiss, with a judge finding plausible price‑fixing claims, while...
On-Site ‘Dialysis Dens’ at Nursing Homes Boost Care Continuity, a Boon for VBC and Hospital Partnerships
On‑site dialysis “dens” are being introduced in nursing homes, with Eduro Healthcare piloting the model at one of its 40 facilities through a partnership with Rendevor Dialysis. The on‑site setup eliminates transport‑related delays, improves care coordination, and gives residents additional...
Is C2 Tilt Causing Pelvic Fixation Failure?
A Washington University study of 517 adult spinal deformity patients found that 31 (6%) experienced pelvic fixation failure, prompting reoperation. Multivariable analysis identified a postoperative C2 Tilt greater than 6.9° as a strong predictor, with an odds ratio of 1.15...
Baltimore to Use $1M in Grant Funding for 911 Diversion Program
Baltimore will use a $1.03 million federal grant to broaden its 911 diversion program, extending services beyond behavioral‑health emergencies to a wider range of non‑violent calls. The funding, secured by Rep. Kweisi Mfume, builds on a program launched in 2021 under a...
Trump Clears Path for Expanded Psychedelic Research to Treat Veterans’ PTSD
President Donald Trump signed an executive order directing the FDA to accelerate reviews of psychedelic therapies and earmarking at least $50 million for ibogaine research aimed at treating veteran PTSD. The order also creates a Right‑to‑Try pathway for severely ill patients...
AACR San Diego 2026: New Drugs on the Horizon
The AACR 2026 Annual Meeting in San Diego unveiled 11 first‑time disclosed oncology candidates spanning small‑molecule degraders, bispecific antibodies, T‑cell engagers and ADCs. Highlights include NEO‑811, a CRBN‑mediated molecular glue targeting HIF‑1β for VHL‑deficient renal cancer, and AZD8359, a STEAP2‑directed T‑cell...
Medical Expert Testimony Vs. Advocacy in the Courtroom
The AMA’s Code of Medical Ethics mandates that physician expert witnesses remain objective, avoiding advocacy that sways juries with legal jargon. Courtroom phrases such as “reasonable degree of medical certainty” lack scientific grounding, yet are routinely used to bolster expert...
Delgocitinib Maintains QOL, Productivity Improvements at 52 Weeks in Chronic Hand Eczema
The open‑label DELTA 3 extension of the phase 3 delgocitinib trials shows that patients with moderate‑to‑severe chronic hand eczema who continued with twice‑daily or as‑needed delgocitinib cream for a full year maintained significant gains in disease‑specific and generic quality‑of‑life scores. Across 472...
How Trump's Psychedelics Executive Order Could Unlock Stalled Cannabis Reform
President Donald Trump signed an executive order that accelerates research, clinical trials, and Right‑to‑Try access for psychedelics such as psilocybin, MDMA and ibogaine, while leaving their scheduling unchanged. The order follows a prior, stalled effort to reschedule cannabis, highlighting the...
The ROI of Beating Cancer
A small early‑stage trial showed that a personalized mRNA vaccine triggered an immune response and extended survival for pancreatic cancer patients, a disease that kills over 90% within five years. Economists estimate that between 1988 and 2000, cancer detection and...
Shock Patients Treated With MCS Devices at Referral Hospitals Have Higher Risks
An observational analysis of 398 cardiogenic shock patients found that temporary mechanical circulatory support (MCS) implanted at regional referral hospitals before transfer to a level‑1 shock center leads to significantly more device‑related adverse events. Bleeding occurred in 29% of referral‑hospital...
Lonvi’s New Capsule Boosts Mouse Lifespan by 9% and Extends Survival 64% in Trials
Lonvi announced that its experimental capsule, built around the grape‑seed compound procyanidin C1, increased overall mouse lifespan by 9.4% and extended survival by 64% from the first day of treatment. The claim, posted on the company’s website and amplified by...
A Protein Engineering Method May Lead to More Exact Cancer Treatments
Researchers at the University of Texas at Dallas unveiled ProSSpeC, a machine‑learning model that predicts protease substrate specificity by mining evolutionary data from thousands of related enzymes. The model identified engineered synthetic proteases that outperformed the commonly used tobacco etch...
Synthetic Biology and Tissue Engineering Grow Liver Tissue In‑Body
Researchers at the Wyss Institute, Boston University and MIT have created a synthetic‑biology platform called BOOST that triggers growth of tiny engineered liver constructs after implantation. By rewiring hepatocytes and fibroblasts with a doxycycline‑controlled YAP protein and four growth‑factor genes,...
Sihuan Pharmaceutical Reports Positive Phase III Data for Dirozalkib in ALK‑Positive NSCLC
Sihuan Pharmaceutical announced on April 20, 2026 that its ALK inhibitor Dirozalkib met primary endpoints in the Phase III DIAMOND‑2 trial for first‑line treatment of ALK‑positive advanced non‑small cell lung cancer. The data, presented at the 2026 AACR meeting, could...
FDA Clears Next-Gen Hybrid System for Intravascular Imaging
Conavi Medical received FDA clearance for its next‑generation hybrid intravascular imaging system that simultaneously performs intravascular ultrasound (IVUS) and optical coherence tomography (OCT). The device builds on the company’s 2018 Novasight Hybrid System and aims to streamline coronary assessments by...
Misinterpretation of Trial Information Can Lead to Misleading Conclusions: Dispiriting SPIRIT- A Response to Greenhalgh Et Al
In a rapid response, the authors of the Medical Masks vs N95 Respirators trial refute Greenhalgh et al’s claim that the study underwent retrospective protocol changes that could bias results. They clarify that the protocol remained unchanged, with universal masking...
Anktiva Needs Trial Data Before FDA Approval
For the umpteenth time, these posters have zero relevance to Anktiva unless, or until, $IBRX conducts/completes randomized clinical trials that demonstrate the drug improves outcomes for cancer patients w/ lymphopenia. @LoriMills4CA42 and the rest of you can idolize @DrPatrick ...
PA Court Strikes Down Ban On Medicaid Payment For Abortions
A Pennsylvania appellate court struck down the state’s ban on using Medicaid funds for abortions, ruling the restriction invalid after Governor Josh Shapiro refused to defend it. The decision restores the ability of Medicaid enrollees to receive abortion services covered...
OpenAI Launches GPT Rosalind for Life Sciences Research
OpenAI has unveiled GPT Rosalind, a large‑language model tuned for life‑sciences research, designed to accelerate early‑stage drug discovery by automating literature review, evidence synthesis, hypothesis generation, and experimental planning. The model outperforms GPT‑5.4 on multiple chemistry, protein‑engineering and genomics benchmarks, and...
The BioPharm Brief: Oncology Innovations Continue with Durable Survival, In Vivo CAR-T, and Combination Therapies
Immunocore reported five‑year overall survival data confirming tebentafusp’s durable benefit in metastatic uveal melanoma, the first T‑cell receptor‑based therapy to show a clear survival advantage in this rare cancer. Eli Lilly announced the acquisition of Kelonia Therapeutics to accelerate in‑vivo CAR‑T...
10x Genomics Launches Atera, a SaaS Platform for Scalable Single‑Cell Spatial Biology
10x Genomics announced Atera, a cloud‑based, subscription‑driven platform that provides whole‑transcriptome spatial analysis with single‑cell sensitivity at scale. Debuted at the AACR 2026 meeting, the service signals a shift toward SaaS models in specialized biotech research.
FDA Grants Priority Review for Merck's KEYTRUDA‑Padcev Combo in Muscle‑Invasive Bladder Cancer
Merck announced that the FDA has placed its KEYTRUDA (pembrolizumab) and KEYTRUDA QLEX (pembrolizumab‑berahyaluronidase) plus Padcev (enfortumab vedotin) combos for cisplatin‑eligible muscle‑invasive bladder cancer under priority review, with a PDUFA decision due Aug 17, 2026. The move follows Phase 3 KEYNOTE‑B15 data showing...
STAT+: In Early Trial, CAR-T Results Raise Hope of Preventing Multiple Myeloma in High-Risk Patients
A phase‑I trial of CAR‑T therapy in high‑risk smoldering multiple myeloma reported that all 20 participants achieved undetectable disease after treatment. The results, presented at the AACR meeting, suggest the possibility of preventing progression to active myeloma, a deeper response...
Top 10 Fastest-Growing Healthcare Companies in 2026, From Financial Times’ List
The Financial Times’ 2026 Americas Fastest‑Growing Companies list spotlights ten U.S. healthcare firms that are scaling rapidly amid a broader surge in health‑service deals and AI‑driven consumer behavior. PwC expects deal volume to climb as buyers chase technology‑enabled businesses, while...
The Doctor Will Post You Now
Physicians face a growing dilemma as patients turn to TikTok, chatbots and other digital platforms to evaluate and choose their providers. Without a visible online presence, doctors risk becoming financially invisible to algorithm‑driven search tools. Existing professional standards, such as...
AB Science: New Publication on Medrxiv Demonstrating Substantial Survival Benefits and Preserved Quality of Life with Masitinib in ALS Patients
AB Science announced a medRxiv preprint showing its tyrosine‑kinase inhibitor masitinib dramatically improves survival for amyotrophic lateral sclerosis (ALS) patients. The data reveal a 5‑year survival rate of 42.3% overall and 52.9% among those treated before complete functional loss, roughly...
Court Rejects Anthem’s Attempt to Relitigate Arbitration Losses Under No Surprises Act
A California federal judge dismissed Anthem's federal claims against billing firm HaloMD, ruling that the No Surprises Act permits only extremely limited judicial review of Independent Dispute Resolution (IDR) arbitration outcomes. The court held that the statute already provides mechanisms...
OUTRAGE: Canadian Government Shielded From Liability After 17-Year-Old Dies Following COVID Vaccine
A Canadian court ruled that the federal government cannot be held liable for the death of 17‑year‑old Sean Hartman, who died 33 days after receiving a Pfizer‑BioNTech COVID‑19 vaccine. The Ontario Court of Appeal upheld the lower court’s dismissal of...
What Other HIMSS Chapters Can Learn From Georgia
HIMSS Georgia has emerged as one of the most active local chapters, according to HIMSS executive Lisa Counsell. The chapter’s success stems from hospitals treating each other as collaborators rather than competitors, fostering a culture of shared learning. Members also...
Re: Recognising Cardiac Syncope and the Short QT Syndrome
A recent BMJ correspondence highlights short QT syndrome as an often‑overlooked cause of cardiac syncope. The author cites a 52‑year‑old patient with a QTc of 327 ms who experienced R‑on‑T extrasystoles and sustained polymorphic ventricular tachycardia. Diagnostic criteria include a QTc...
Trump, FDA Plan to Expedite Psychedelic Development
President Donald Trump publicly endorsed psychedelic medicines as a breakthrough for severe mental health disorders, pledging to fast‑track their research and development. The White House announcement coincides with the FDA’s plan to create an accelerated review pathway for psychedelic drug...
25 of 32 Years of Life Expectancy Came From This
U.S. life expectancy rose from 47 years in 1900 to roughly 79 years by 2025, with clean water and sanitation responsible for 25 of the 32‑year gain. Vaccinations added another 25‑plus years, while modern medical treatments contributed only five years....
Regulatory Tips From a Breakthrough Noninvasive Device Startup
Compremium’s Quantis CVP, a noninvasive central venous pressure monitor, received FDA Breakthrough Device designation in January 2026 and subsequently joined the agency’s Total Product Life Cycle Advisory Program (TAP). The CTO explained that TAP eligibility hinges on prior acceptance into the...
UnitedHealthcare Reduces Need For Prior Approvals For Patients In Rural America
UnitedHealthcare announced it will exempt rural physicians and hospitals from most prior‑authorization requirements across all lines of business. The plan also speeds payments by up to 50% for roughly 1,500 rural and Critical Access Hospitals and introduces hub‑and‑spoke partnerships to...
Inside 3/11 Viral Takeover: My In-Depth Interview with Dr John Campbell
In an extensive interview with Dr. John Campbell, author Sonia Elijah delves into the core arguments of her book *3/11 Viral Takeover*, which examines the COVID‑19 pandemic’s origins and aftermath. The conversation spotlights flawed PCR testing, the sidelining of Great...
Garlic-Derived DAS Outperforms Metformin, Extending Mouse Lifespan
👉 “Chronic treatment with DAS (found in garlic 🧄) freshly added to the diet weekly revealed geroprotective effects, since it extended lifespan and improved metabolic homeostasis, locomotor function, and relevant cognitive parameters in wild-type male mice fed with an STD....
China Debuts Pharmacy Robot Processing 370 Orders Daily
China Launches First Pharmacy #Robot Handling 370 Orders a Day by @CGTNOfficial #MedTech #HealthTech #Tech #Healthcare https://t.co/DjZ0teE6fF
FDA Grants Priority Review for Padcev Plus Keytruda in Bladder Cancer Treatment
The U.S. Food and Drug Administration has granted Priority Review to the peri‑operative combination of Padcev (enfortumab vedotin) and Keytruda (pembrolizumab) for muscle‑invasive bladder cancer (MIBC). The Phase 3 EV‑304 trial demonstrated a 47% reduction in recurrence, progression or death and a...
Vaccinated Donor Plasma Contains No Spike Proteins or mRNA
One of the top questions I get about young plasma exchange (YPE): “What if the donor was vaccinated? Does that mean I’m getting spike proteins or mRNA injected into me?” Short answer: No. Here’s the breakdown... https://t.co/JDoAi2yPmR
GLP‑1 Drugs Aren’t a One‑size‑fit Solution
Should everyone be taking a GLP-1 medication? From my discussion with @RealDoctorMike on his podcast https://t.co/d3M8cFHggz
Novartis Cuts Two Programs in Cancer-Related Blood Clots
Novartis announced the termination of two late‑stage programs targeting cancer‑related blood clots after a pivotal trial demonstrated inferior efficacy versus existing anticoagulants. The candidates, one of which Novartis out‑licensed in 2019, were being developed to address the high unmet need...
Higher Muscle Strength Cuts Mortality Risk in Elderly Women
Muscular Strength and Mortality in Women Aged 63 to 99 Years 👉 “this study of ambulatory older women, greater muscular strength was associated with lower mortality even when controlling for accelerometer-measured PA and sedentary time, walking speed, and systemic inflammation.” https://t.co/xi913FibKy
AI's First Use Turns Skeptical Radiologists Into Advocates
In healthcare, you only understand how game-changing AI is once you use it. What strikes me most is how reliably opinions flip. The skeptic radiologist goes from “I don’t need this” to “I can’t imagine working without it.” Not occasionally. Almost every time.
GLP‑1s Preserve Muscle Better Than Diet‑Only Weight Loss
Summary for patients on GLP-1 drugs and non-drug weight loss re: muscle mass impact @AnnalsofIM https://t.co/pSDhbKkXwb https://t.co/qM7OgVJwQg